Onxeo Receives Notice of Allowance for a New Patent Broadening the Protection of AsiDNA™ in combination with a PARP Inhibitor in the United States

NEXT STORY
Computer Vision in Healthcare Market to Project Lucrative CAGR of 47.3% from 2020-2027 | Market Research Future (MRFR)
PREV STORY
Artificial Intelligence in the Pharmaceutical market worth US$27,156.1 Million in 2031. Visiongain Research Inc.
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Phathom Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Clinical Trial Status and Business Updates

author_avatar
NASDAQ Market News

[Ad hoc announcement pursuant to Art. 53 LR] Phase III study shows Roche’s Polivy plus R-CHP is the first regimen in 20 years to significantly improve outcomes in previously untreated aggressive form of lymphoma compared to standard of care

author_avatar
NASDAQ Market News

G1 Therapeutics and Boehringer Ingelheim Announce Co-Promotion Agreement for Trilaciclib in Small Cell Lung Cancer in the United States and Puerto Rico

author_avatar
NASDAQ Market News